Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
MDU Resources
MDU
$4.27B
| $47M | 0.03% |
4,599,403
+453,655
| +11% | +$4.65M |
|
|
MFA
627
MFA Financial
MFA
$931M
| $46.9M | 0.03% |
1,481,569
+597,135
| +68% | +$19.7M |
|
|
FISV
628
Fiserv Inc
FISV
$29.5B
| $46.7M | 0.03% |
+712,974
| New | +$46M |
|
629
PUT
Bath & Body Works
BBWI
$3.76B
| $46.4M | 0.03% |
952,737
+342,030
| +56% | +$13.8M |
|
630
Gaming and Leisure Properties
GLPI
$12.7B
| $46.3M | 0.03% |
1,252,635
+669,944
| +115% | +$24.4M |
|
|
OPTU
631
Optimum Communications Inc
OPTU
$228M
| $46.3M | 0.03% |
2,182,939
+1,005,146
| +85% | +$22.3M |
|
632
Blackstone Mortgage Trust
BXMT
$2.44B
| $46.2M | 0.03% |
+1,435,977
| New | +$46.1M |
|
633
PUT
Humana
HUM
$46.2B
| $45.9M | 0.03% |
185,200
+116,400
| +169% | +$28.7M |
|
634
Allegiant Air
ALGT
$2.36B
| $45.9M | 0.03% |
+296,364
| New | +$41.9M |
|
635
PUT
ConocoPhillips
COP
$150B
| $45.7M | 0.03% |
832,800
-438,000
| -34% | -$22.5M |
|
|
EFOR
636
Everforth Inc
EFOR
$1.37B
| $45.5M | 0.03% |
707,657
+674,470
| +2,032% | +$40.8M |
|
637
CALL
Cognizant
CTSH
$26.7B
| $45.3M | 0.03% |
637,500
+45,700
| +8% | +$3.34M |
|
|
EA
638
DELISTED
Electronic Arts
EA
| $45.2M | 0.03% |
430,612
+416,470
| +2,945% | +$46.3M |
|
639
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $45.2M | 0.03% |
597,800
+295,000
| +97% | +$21.5M |
|
640
Bread Financial
BFH
$4.51B
| $45.1M | 0.03% |
223,055
-131,890
| -37% | -$24.4M |
|
641
CALL
Bristol-Myers Squibb
BMY
$132B
| $45.1M | 0.03% |
736,000
-165,300
| -18% | -$10.3M |
|
642
PUT
Southwest Airlines
LUV
$22B
| $45.1M | 0.03% |
688,500
+405,300
| +143% | +$23.8M |
|
|
ESRX
643
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $45.1M | 0.03% |
603,700
+450,400
| +294% | +$28.8M |
|
644
International Flavors & Fragrances
IFF
$21.4B
| $45M | 0.03% |
295,049
-379,157
| -56% | -$57M |
|
|
RHT
645
PUT
DELISTED
Red Hat Inc
RHT
| $45M | 0.03% |
374,700
+147,400
| +65% | +$18.1M |
|
646
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$340M
| $45M | 0.03% |
389,200
-11,700
| -3% | -$1.33M |
|
647
Viavi Solutions
VIAV
$10.6B
| $44.7M | 0.03% |
5,119,619
+2,105,307
| +70% | +$19.1M |
|
648
PUT
Valero Energy
VLO
$98.7B
| $44.7M | 0.03% |
486,200
-175,400
| -27% | -$14.5M |
|
|
Y
649
DELISTED
Alleghany Corp
Y
| $44.6M | 0.03% |
74,856
+72,979
| +3,888% | +$41.6M |
|
650
PUT
Pfizer
PFE
$153B
| $44.5M | 0.03% |
1,294,207
+146,085
| +13% | +$4.98M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.